Do we really need continuous vancomycin infusion in neonates?

Archives of Disease in Childhood

Volumn 98, Issue 12, 2013, Pages 1023-1024

  Samiee Zafarghandy, Samira ^a   Van Den Anker, John N ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

BLOOD LEVEL; CONTINUOUS INFUSION; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG USE; HOSPITALIZED INFANT; HUMAN; KIDNEY FUNCTION; LETTER; LOADING DRUG DOSE; NEWBORN CARE; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; STEADY STATE;

NEONATOLOGY; PHARMACOLOGY;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; VANCOMYCIN;

EID: 84888642740     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304687     Document Type: Letter

References (4)

1. Zhao W, Lopez E, Biran V, et al. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child 2013;98:449-53.
2. Pacifici GM, Allegaert K. Clinical pharmacokinetics of vancomycin in the neonate: a review. Clinics 2012;67:831-7.
3. Pawlotsky F, Thomas A, Kergueris MF, et al infusion of vancomycin in premature neonates: a new dosage schedule. Br J Clin Pharmacol 1998;46:163-7.
4. de Hoog M, Schoemaker RC, Mouton JW, et al. Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther 2000;67:360-7.